Orlynvah is used to treat uncomplicated urinary tract infections caused by certain microorganisms in adult women who have limited or no alternative oral antibacterial treatment options.
FRG, its operating businesses and the company's other affiliates, commenced voluntary Chapter 11 proceedings in the U.S. Bankruptcy Court for the District of Delaware.